Detailed answers about CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED, including incorporation, status, business activity, and accounts information.
When was CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED founded?
CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED was officially incorporated on 24 November 2022 and is registered under company number 14503558. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED?
CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED do?
CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED operates in the following sector: 96090 - Other service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED's registered address?
The registered office address of CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED is 71 FINSTALL CLOSE, BIRMINGHAM, ENGLAND, B7 4LA. This is the official address filed with Companies House for legal and statutory correspondence.
Is CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED financially stable?
The most recent accounts for CLEARERCARE PODIATRY NORTH WARWICKSHIRE LIMITED were made up to 30 November 2024, filed as MICRO ENTITY. Next accounts are due by 31 August 2026.